HOT NEWS
Merck
Merck & Co., Inc.Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com.

Merck RSS Channel

Title Filter     Display # 
# Article Title Hits
1 Single Treatment with ELONVA® Produced Live Birth Rates Comparable to Daily rFSH Injections 1071
2 New SIMPONI™ (Golimumab) Data Shows Sustained Efficacy in the Treatment of Rheumatoid Arthritis 1637
3 New Study Shows Rheumatoid Arthritis Patients Report Need for Improvement in Subcutaneous Therapy Delivery Devices 1183
4 Merck Announces Launch of Pioneering Collaborative Cancer Trials Network 982
5 Results of the clinical study CALYPSO Published in The Journal of Clinical Oncology 1286
6 Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy 1114
7 Merck Announces First-Quarter 2010 Financial Results 883
8 Merck Receives European Approval for ELONVA® (corifollitropin alfa injection) 2028
9 New Merck Begins Operations 1112
10 Merck and Schering-Plough to Merge 2036
11 Pivotal Study Evaluating Efficacy of GARDASIL 887
12 Merck Reaffirms Cardiovascular Research Commitment 794
 
Bookmark and Share